Company profile
iMD Companies, Inc.
OTC: ICBU · Healthcare · Medical - Diagnostics & Research
PublicHQ Rancho Cordova, FLReports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
47DFH 54DQ —GM 26SS 47
v0.1 · 45/100 weight · provisional
↑ return on assets, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
$418.4k
Employees
5
as of 2026-08-24
Market cap
$2.0M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income$418.4k$418.4k2025
Operating income-$178.2k-$178.2k2025
Total assets$357.8k$357.8k2025
Liabilities$2.4M$2.4M2025
Equity-$2.1M-$2.1M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is iMD Companies, Inc.’s revenue?
iMD Companies, Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.
Peers · Healthcare
Lifeline Biotechnologies, Inc.——Nu-Med Plus, Inc.23DGenprex, Inc.34DTelo Genomics Corp.——Lobe Sciences Ltd.42DDakshidin Corporation31DKey facts
CEORichard Wilson
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersRancho Cordova, FL
ExchangeOTC: ICBU
Employees5
IPO date1996-08-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.